Retatrutide 10 mg is the entry-strength lyophilised vial supplied by BuyRetaUK — a small, self-contained presentation suited to short in-vitro workflows, method development and low-volume pilot studies where a compact peptide mass avoids over-aliquoting.
Retatrutide 10 mg is a 10-milligram lyophilised research-peptide vial released to ≥99% HPLC-UV with mass-spectrometric identity. It is the smallest presentation in the BuyRetaUK Retatrutide range and typically selected for short in-vitro runs or method-development work.
Retatrutide 10 mg is a single lyophilised vial containing 10 milligrams of Retatrutide (LY3437943), a synthetic triple receptor agonist active at the GLP-1, GIP and glucagon receptors. It is the smallest presentation stocked at BuyRetaUK and the natural first choice for laboratories running short, well-scoped in-vitro protocols.
For the underlying compound science — receptor pharmacology, structure and research context — see the cornerstone What is Retatrutide? guide.
The natural step up from 10 mg is the Retatrutide 20 mg vial — twice the mass at a lower per-milligram cost, and typically the right call once a study will consume more peptide than one 10 mg vial provides. Both are released to the same specification; only the packaged mass differs. The Strengths Hub lays out the full 10 → 40 mg ladder.
Every vial ships with a batch-specific COA · UK dispatch
Every 10 mg vial ships with a batch-specific Certificate of Analysis reporting HPLC-UV purity, identity, appearance and, where applicable, moisture and endotoxin. Cross-check the batch number on the vial label against the corresponding entry in the verification library. For a section-by-section walk-through of the certificate, see the Certificate of Analysis guide.
The 10 mg vial is released against the same ≥99% HPLC-UV area-percent specification as the 20, 30 and 40 mg presentations, with orthogonal identity confirmation by mass spectrometry. Full method context — chromatography theory, impurity profiling — lives in the Retatrutide Purity reference.
Store sealed 10 mg vials at 2–8 °C short-term and at −20 °C for extended holding. Reconstituted working stock is stable at 2–8 °C for up to 30 days, or frozen as single-use aliquots for longer programmes. Full cold-chain framework in the Retatrutide Storage guide.
Reverse-phase HPLC quantifies purity as a percentage of total peak area. Release specification: ≥99%.
Learn more →Certificate of AnalysisEvery batch ships with a batch-specific COA reporting identity, purity and appearance.
Learn more →Laboratory QualityIndependent third-party analysis, temperature-controlled UK storage and full batch traceability.
Learn more →Batch VerificationCross-reference the batch number printed on your vial against our live COA library.
Learn more →Storage StandardsLyophilised at 2–8°C protected from light. Reconstituted stability ~30 days at 2–8°C.
Learn more →10 mg suits short or single-run protocols — for extended studies, step up to 20 mg or higher.
Decide diluent volume before opening the vial; a 10 mg cake is easily over-diluted.
Cross-reference the vial batch number against the published Certificate of Analysis before use.
Have 2–8 °C storage ready on arrival; freezer aliquots should be prepared straight after reconstitution.
10 mg is the smallest presentation BuyRetaUK stocks. It suits laboratories running short in-vitro pilots, refining assay conditions, or performing method-development runs where a compact peptide mass reduces waste from a partially used higher-strength vial.
Reconstituting a 10 mg vial in 1 mL of bacteriostatic water yields 10 mg/mL; in 2 mL yields 5 mg/mL; in 5 mL yields 2 mg/mL. The reconstitution calculator handles any target concentration.
Choose 20 mg when a study will consume more than one 10 mg vial's worth of peptide, or when a single larger reconstitution simplifies workflow. Both are released to the same ≥99% HPLC-UV specification, so per-milligram economics usually favour the larger vial for extended studies.
No. Every Retatrutide vial — 10 mg through 40 mg — is manufactured under the same synthesis and release specification, with identical HPLC-UV purity and ESI-MS identity confirmation reported on the batch-specific Certificate of Analysis.
Yes. After reconstitution the working stock can be aliquoted into single-use portions and frozen. Freeze once, thaw once — the storage guide covers freeze-thaw handling in detail.
No. All BuyRetaUK Retatrutide vials, including 10 mg, are supplied for in-vitro laboratory research only and are not intended for human or veterinary administration.
Peer-reviewed citations are added as each article is expanded. See our editorial standards for our sourcing and accuracy commitments.
The BuyRetaUK editorial team publishes laboratory-focused reference content on research peptides, analytical methods and Certificates of Analysis. All articles are written for in-vitro research contexts only.
View profile →Every editorial article is reviewed against our accuracy commitment and quality-assurance checklist before publication. Named reviewer profiles are added as our reviewer network expands.
View profile →Every article follows a documented editorial process — sourcing, scientific review, update cadence and correction policy — so researchers can rely on what we publish.
Read the full editorial standards →Educational first. Each step is optional — start wherever you are in your research.
Compound overview, receptor profile and research framing.
Triple vs dual incretin agonist — how they differ.
Triple agonist vs single GLP-1 agonist.
How to verify identity, purity and batch quality.
Every retatrutide variant with lab data.
Solvent volume and dose-per-unit calculator.
Triple vs dual incretin agonist — receptor profile and research framing.
View comparison →Side by sideTriple agonist vs single GLP-1 — class, mechanism and lab context.
View comparison →Multi-compoundAll GLP-1 / GIP / glucagon research compounds in one place.
View comparison →A laboratory overview of retatrutide (LY3437943) — a triple agonist research peptide acting on the GLP-1, GIP and glucagon receptors.
6 min read →Storage & HandlingHow to store lyophilised research peptides and reconstitute them correctly for laboratory use.
4 min read →RetatrutideBackground on retatrutide in the academic literature — receptor pharmacology, study context and analytical handling.
8 min read →Product ComparisonsSide-by-side comparison of retatrutide and tirzepatide across receptor profile, research context and analytical considerations.
5 min read →Every batch of Retatrutide ships with a third-party HPLC and mass-spec Certificate of Analysis. Browse the live COA library to verify your lot.
Long-term frozen storage (-20°C) is acceptable for lyophilised vials, but routine refrigerated storage at 2–8°C is sufficient for typical research timelines.
Read: Storage & Reconstitution →No. Retatrutide is supplied strictly for laboratory research and is not approved for human or veterinary administration.
Read: What is Retatrutide? →In published research it has been characterised as a triple agonist acting on the GLP-1, GIP and glucagon receptors.
Read: What is Retatrutide? →Lyophilised vials are stored at 2–8°C, protected from light. Once reconstituted with bacteriostatic water, store refrigerated and use within 30 days.
Read: What is Retatrutide? →
